Rifinah 300 is a combination medication used primarily in the treatment and prevention of tuberculosis (TB). It contains two active ingredients: rifampicin (also known as rifampin in some regions) and isoniazid. These components work together to kill the bacteria that cause TB. Rifampicin works by inhibiting the synthesis of RNA within the bacteria, thereby stopping their ability to make proteins and replicate. Isoniazid interferes with the production of mycolic acid, a component necessary for the bacterial cell wall. The combination of these two drugs is effective in preventing the development of resistance that the bacteria might develop when exposed to a single antibiotic. Rifinah 300 is typically used in the initial phases of TB treatment and may be prescribed for other conditions as determined by a healthcare provider. It is important for patients to follow their healthcare provider's instructions closely when taking Rifinah 300 to ensure the best possible outcome and to minimize the risk of side effects or drug resistance.